Skip to main content
Erschienen in: Clinical and Experimental Nephrology 3/2016

05.02.2016 | Commentary

Accurate estimation of protein/creatinine ratio on urine sample in CKD patients

verfasst von: Kensei Taguchi, Seiji Ueda, Kei Fukami

Erschienen in: Clinical and Experimental Nephrology | Ausgabe 3/2016

Einloggen, um Zugang zu erhalten

Excerpt

Chronic kidney diseases (CKD) is common in general population and is associated with increased risk for end stage renal disease (ESRD), its complications and mortality. The number of patients with ESRD requiring maintenance dialysis or transplantation is increasing worldwide and the costs associated with the care of those are estimated to exceed US$1 trillion. Therefore, the discovery of novel and accurate biomarker for evaluating the risk of CKD patients is needed. So far, proteinuria and/or albuminuria are widely recognized as a pivotal predictor of risk for the development and progression of CKD and cardiovascular disease (CVD) [1]. …
Literatur
1.
Zurück zum Zitat Halbesma N, Kuiken DS, Gansevoort RT, et al. Macroalbuminuria is a better risk marker than low estimated GFR to identify individuals at risk for accelerated GFR loss in population screening. J Am Soc Nephrol. 2006;17(9):2582–90.CrossRefPubMed Halbesma N, Kuiken DS, Gansevoort RT, et al. Macroalbuminuria is a better risk marker than low estimated GFR to identify individuals at risk for accelerated GFR loss in population screening. J Am Soc Nephrol. 2006;17(9):2582–90.CrossRefPubMed
2.
Zurück zum Zitat Motoyoshi Y, Matsusaka T, Ichikawa I, et al. Megalin contributes to the early injury of proximal tubule cells during nonselective proteinuria. Kidney Int. 2008;74(10):1262–9.CrossRefPubMedPubMedCentral Motoyoshi Y, Matsusaka T, Ichikawa I, et al. Megalin contributes to the early injury of proximal tubule cells during nonselective proteinuria. Kidney Int. 2008;74(10):1262–9.CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Zhang Z, Shahinfar S, Snapinn SM, et al. Importance of baseline distribution of proteinuria in renal outcomes trials: lessons from the reduction of endpoints in NIDDM with the angiotensin II antagonist losartan (RENAAL) study. J Am Soc Nephrol. 2005;16(6):1775–80.CrossRefPubMed Zhang Z, Shahinfar S, Snapinn SM, et al. Importance of baseline distribution of proteinuria in renal outcomes trials: lessons from the reduction of endpoints in NIDDM with the angiotensin II antagonist losartan (RENAAL) study. J Am Soc Nephrol. 2005;16(6):1775–80.CrossRefPubMed
4.
Zurück zum Zitat Iseki K, Ikemiya Y, Takishita S, et al. Proteinuria and the risk of developing end-stage renal disease. Kidney Int. 2003;63(4):1468–74.CrossRefPubMed Iseki K, Ikemiya Y, Takishita S, et al. Proteinuria and the risk of developing end-stage renal disease. Kidney Int. 2003;63(4):1468–74.CrossRefPubMed
5.
Zurück zum Zitat Gerstein HC, Mann JF, Yusuf S, et al. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA. 2001;286(4):421–6.CrossRefPubMed Gerstein HC, Mann JF, Yusuf S, et al. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA. 2001;286(4):421–6.CrossRefPubMed
6.
Zurück zum Zitat Arnlöv J, Evans JC, Vasan RS, et al. Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham Heart Study. Circulation. 2005;112(7):969–75.CrossRefPubMed Arnlöv J, Evans JC, Vasan RS, et al. Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham Heart Study. Circulation. 2005;112(7):969–75.CrossRefPubMed
7.
Zurück zum Zitat Zandbergen AA, Vogt L, Bootsma AH, et al. Change in albuminuria is predictive of cardiovascular outcome in normotensive patients with type 2 diabetes and microalbuminuria. Diabetes Care. 2007;30(12):3119–21.CrossRefPubMed Zandbergen AA, Vogt L, Bootsma AH, et al. Change in albuminuria is predictive of cardiovascular outcome in normotensive patients with type 2 diabetes and microalbuminuria. Diabetes Care. 2007;30(12):3119–21.CrossRefPubMed
8.
Zurück zum Zitat Gaspari F, Perico N, Remuzzi G. Timed urine collections are not needed to measure urine protein excretion in clinical practice. Am J Kidney Dis. 2006;47(1):1–7.CrossRefPubMed Gaspari F, Perico N, Remuzzi G. Timed urine collections are not needed to measure urine protein excretion in clinical practice. Am J Kidney Dis. 2006;47(1):1–7.CrossRefPubMed
9.
Zurück zum Zitat Ruggenenti P, Gaspari F, Remuzzi G, et al. Cross sectional longitudinal study of spot morning urine protein:creatinine ratio, 24 hour urine protein excretion rate, glomerular filtration rate, and end stage renal failure in chronic renal disease in patients without diabetes. BMJ. 1998;316(7130):504–9.CrossRefPubMedPubMedCentral Ruggenenti P, Gaspari F, Remuzzi G, et al. Cross sectional longitudinal study of spot morning urine protein:creatinine ratio, 24 hour urine protein excretion rate, glomerular filtration rate, and end stage renal failure in chronic renal disease in patients without diabetes. BMJ. 1998;316(7130):504–9.CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Piller LB, Ford CE, Probstfield JL, et al. Incidence and predictors of angioedema in elderly hypertensive patients at high risk for cardiovascular disease: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). J Clin Hypertens (Greenwich). 2006;8(9):649–56.CrossRef Piller LB, Ford CE, Probstfield JL, et al. Incidence and predictors of angioedema in elderly hypertensive patients at high risk for cardiovascular disease: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). J Clin Hypertens (Greenwich). 2006;8(9):649–56.CrossRef
11.
Zurück zum Zitat Forbes GB, Bruining GJ. Urinary creatinine excretion and lean body mass. Am J Clin Nutr. 1976;29(12):1359–66.PubMed Forbes GB, Bruining GJ. Urinary creatinine excretion and lean body mass. Am J Clin Nutr. 1976;29(12):1359–66.PubMed
12.
Zurück zum Zitat Baxmann AC, Ahmed MS, Heilberg IP, et al. Influence of muscle mass and physical activity on serum and urinary creatinine and serum cystatin C. Clin J Am Soc Nephrol. 2008;3(2):348–54.CrossRefPubMedPubMedCentral Baxmann AC, Ahmed MS, Heilberg IP, et al. Influence of muscle mass and physical activity on serum and urinary creatinine and serum cystatin C. Clin J Am Soc Nephrol. 2008;3(2):348–54.CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Moon SJ, Kim TH, Hwang HJ, et al. Relationship between stage of chronic kidney disease and sarcopenia in Korean Aged 40 years and older using the Korea National Health and Nutrition Examination Surveys (KNHANES IV-2, 3, and V-1, 2), 2008–2011. PLoS ONE. 2015;10(6):e0130740.CrossRefPubMedPubMedCentral Moon SJ, Kim TH, Hwang HJ, et al. Relationship between stage of chronic kidney disease and sarcopenia in Korean Aged 40 years and older using the Korea National Health and Nutrition Examination Surveys (KNHANES IV-2, 3, and V-1, 2), 2008–2011. PLoS ONE. 2015;10(6):e0130740.CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Tanaka T, Okamura T, Hashimoto T, et al. A simple method to estimate populational 24-h urinary sodium and potassium excretion using a casual urine specimen. J Hum Hypertens. 2002;16(2):97–103.CrossRefPubMed Tanaka T, Okamura T, Hashimoto T, et al. A simple method to estimate populational 24-h urinary sodium and potassium excretion using a casual urine specimen. J Hum Hypertens. 2002;16(2):97–103.CrossRefPubMed
16.
Zurück zum Zitat Chen CF, Yang WC, Lin CC, et al. Urinary protein/creatinine ratio weighted by estimated urinary creatinine improves the accuracy of predicting daily proteinuria. Am J Med Sci. 2015;349(6):477–87.CrossRefPubMed Chen CF, Yang WC, Lin CC, et al. Urinary protein/creatinine ratio weighted by estimated urinary creatinine improves the accuracy of predicting daily proteinuria. Am J Med Sci. 2015;349(6):477–87.CrossRefPubMed
Metadaten
Titel
Accurate estimation of protein/creatinine ratio on urine sample in CKD patients
verfasst von
Kensei Taguchi
Seiji Ueda
Kei Fukami
Publikationsdatum
05.02.2016
Verlag
Springer Japan
Erschienen in
Clinical and Experimental Nephrology / Ausgabe 3/2016
Print ISSN: 1342-1751
Elektronische ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-016-1229-0

Weitere Artikel der Ausgabe 3/2016

Clinical and Experimental Nephrology 3/2016 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.